Dionaldo, Arfel C.
HRN: 28-23-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
CEFTRIAXONE 1G (VIAL)
12/09/2025
12/16/2025
IV
2g
OD
T/C TBI
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes